GGrantIndex
← Leaderboards

Brian J Nickoloff

Loyola University Chicago

$8,337,580
Attributed
$8,337,580
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY200509
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09

Funding mix

By agency

NIH$8,337,580 · 7

By mechanism

R01$6,296,475 · 4
P01$2,041,105 · 3

Top collaborators

No co-investigators on record.

Most similar at Loyola University Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Keratinocyte

Research focus

KeratinocyteScid MouseSkinHuman TissueCytokineTissue /Cell CultureHuman SubjectApoptosisT LymphocyteSkin TransplantationClinical ResearchTumor Necrosis Factor AlphaBaseBiopsyLaboratory MouseDendritic CellsPsoriasisLeukocyte Activation /TransformationMolecular PathologyAreaAnimal ModelCellsFunctional DisorderCell Proliferation

Grant awards (31)

Immunopathogenesis of Psoriasis$385,390
R01 · FY2009 · AR · contact PI
Regulation of Premature Keratinocyte Apoptosis in GVHD$465,728
P01 · FY2008 · CA · contact PI
Immunopathogenesis of Psoriasis$374,204
R01 · FY2008 · AR · contact PI
Core--Skin Analysis and Epidermal Engineering$144,846
P01 · FY2008 · CA · contact PI
Regulation of Premature Keratinocyte Apoptosis in GVHD$464,737
P01 · FY2007 · CA · contact PI
Immunopathogenesis of Psoriasis$370,760
R01 · FY2007 · AR · contact PI
Core--Skin Analysis and Epidermal Engineering$144,099
P01 · FY2007 · CA · contact PI
Immunopathogenesis of Psoriasis$370,754
R01 · FY2006 · AR · contact PI
Cell Death in Normal and Diseased Human Epidermis$291,032
R01 · FY2006 · AR · contact PI
Regulation of Premature Keratinocyte Apoptosis in GVHD$215,572
P01 · FY2006 · CA · contact PI
Core--Skin Analysis and Epidermal Engineering$66,478
P01 · FY2006 · CA · contact PI
Immunopathogenesis of Psoriasis$380,785
R01 · FY2005 · AR
PHENOTYPE AND FUNCTION OF SENESCENT KERATINOCYTES$380,000
R01 · FY2005 · AR
Cell Death in Normal and Diseased Human Epidermis$298,035
R01 · FY2005 · AR
Regulation of Premature Keratinocyte Apoptosis in GVHD$211,347
P01 · FY2005 · CA
Core--Skin Analysis and Epidermal Engineering$64,815
P01 · FY2005 · CA
PHENOTYPE AND FUNCTION OF SENESCENT KERATINOCYTES$380,000
R01 · FY2004 · AR
Cell Death in Normal and Diseased Human Epidermis$323,010
R01 · FY2004 · AR
Regulation of Premature Keratinocyte Apoptosis in GVHD$200,482
P01 · FY2004 · CA
Core--Skin Analysis and Epidermal Engineering$63,001
P01 · FY2004 · CA
PHENOTYPE AND FUNCTION OF SENESCENT KERATINOCYTES$342,000
R01 · FY2003 · AR
Cell Death in Normal and Diseased Human Epidermis$323,010
R01 · FY2003 · AR
PHENOTYPE AND FUNCTION OF SENESCENT KERATINOCYTES$342,000
R01 · FY2002 · AR
Cell Death in Normal and Diseased Human Epidermis$323,010
R01 · FY2002 · AR
IMMUNOPATHOGENESIS OF PSORIASIS$270,880
R01 · FY2002 · AR
Dendritic cell-based vaccines in stage IV melanoma patients$0
P01 · FY2002 · CA
PHENOTYPE AND FUNCTION OF SENESCENT KERATINOCYTES$342,000
R01 · FY2001 · AR
IMMUNOPATHOGENESIS OF PSORIASIS$264,446
R01 · FY2001 · AR
Dendritic cell-based vaccines in stage IV melanoma patients$0
P01 · FY2001 · CA
HHV 8 AND KAPOSIS SARCOMA$276,963
R01 · FY2000 · CA
IMMUNOPATHOGENESIS OF PSORIASIS$258,196
R01 · FY2000 · AR